↓ Skip to main content

Cochrane Database of Systematic Reviews

Diclofenac with or without an antiemetic for acute migraine headaches in adults

Overview of attention for article published in this source, February 2012
Altmetric Badge

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page
wikipedia
15 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
21 Mendeley
Title
Diclofenac with or without an antiemetic for acute migraine headaches in adults
Published by
John Wiley & Sons, Ltd, February 2012
DOI 10.1002/14651858.cd008783.pub2
Pubmed ID
Authors

Derry, Sheena, Rabbie, Roy, Moore, R Andrew

Abstract

Migraine is a common, disabling condition and a burden for the individual, health services and society. Many sufferers choose not to, or are unable to, seek professional help and rely on over-the-counter (OTC) analgesics. Diclofenac is an established analgesic, and new formulations using the potassium or epolamine salts, which can be dissolved in water, have been developed for rapid absorption, which may be beneficial in acute migraine. Co-therapy with an antiemetic should help to reduce the nausea and vomiting commonly associated with migraine.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 14%
Other 2 10%
Student > Doctoral Student 2 10%
Student > Master 2 10%
Student > Bachelor 1 5%
Other 2 10%
Unknown 9 43%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Environmental Science 1 5%
Psychology 1 5%
Neuroscience 1 5%
Other 0 0%
Unknown 10 48%